Home » Topics » Conferences

Conferences
RSS

Lp(a)-dependent actions of LMWH

July 14, 1997

Newer valpromide analogues for treating epilepsy

July 14, 1997

Once-daily extended-release venlafaxine evaluated in depression

July 11, 1997

Pharmacokinetic, drug interaction and clinical results with ziprasidone

July 11, 1997

Phase II/III results for Seroquel

July 11, 1997

Natural products for hyperlipidemia

July 11, 1997

ETA receptor blockade for counteracting effects of angiotensin II

July 11, 1997

n-3 fatty acids for prevention of restenosis

July 11, 1997

Immunological effects of HMG-CoA reductase inhibitors in humans

July 11, 1997

Magnesium implicated in death from cardiovascular disease

July 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...